Dana Roque, MD
Gynecologic Oncology · Baltimore, MDNPI 1588869994
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,119 of the $1,665 with a category attached, or 67.2%. Intuitive Surgical accounts for 76.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $1,293 and has fallen 82.0% since, to $233 in 2025.
Across 14 payments — averaging $118.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Medtronic$216
- GSK$103
- Johnson & Johnson$53
- Merck$28
Across 65 payments — averaging $14,477 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$435K
- R-pharm US LLC$313K
- Merck$122K
- Alkermes, Inc.$71K
What the payments were for
- Travel & lodging$1,11967%
- Food & beverage$54633%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $1,265 |
| Medtronic | 3 | $216 |
| GSK | 1 | $103 |
| Johnson & Johnson | 3 | $53 |
| Merck | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,213
- JEMPERLI$103
How this compares
$1,665 in reported general payments places this provider in the 65th percentile of 35 gynecologic oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LenvimaLenvatinib Mesylate | 12 | $256,696 |
| Erlotinib Hcl | 12 | $6,392 |
| Fentanyl | 15 | $4,013 |
| Megestrol Acetate | 18 | $738 |
| Oxycodone Hcl | 65 | $489 |
| Medroxyprogesterone Acetate | 25 | $313 |
| Oxybutynin Chloride | 13 | $294 |
| Estradiol | 11 | $266 |
| Ondansetron Hcl | 25 | $255 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $255 |
| Gabapentin | 25 | $194 |
| Prochlorperazine Maleate | 19 | $159 |
| Potassium Chloride | 18 | $147 |
| Tramadol Hcl | 12 | $72 |
| Triamcinolone Acetonide | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Baltimore
- Dwight ImBaltimore$93K
- Amanda Nickles-FaderBaltimore$21K
- Kara Long RocheBaltimore$5K
- Neil RosensheinBaltimore$5K
- Sarah LynamBaltimore$3K
- Amanda RamosBaltimore$3K
- Beman KhulpateeaBaltimore$2K
- Christine O ConnorBaltimore$1K
- Hyung RyuBaltimore$973
- Teresa Diaz-MontesBaltimore$887
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.